Pulmonary manifestations of the idiopathic inflammatory myopathies in a South African population
Main Article Content
Abstract
Background. Pulmonary complications cause significant morbidity and mortality in patients with idiopathic inflammatory myopathies (IIMs).
Objectives. To describe the frequency and spectrum of pulmonary complications in patients with IIMs in South Africa (SA).
Methods. A retrospective records review of adult patients with IIMs or clinically amyopathic dermatomyositis (CADM) presenting with respiratory complaints at a tertiary care facility in SA was performed. Clinical features, results of laboratory and pulmonary function tests (PFTs), radiological findings and treatment were recorded.
Results. Pulmonary complications were documented in 66 patients. Most patients (n=41; 62.1%) had dermatomyositis, 14 (21.2%) had polymyositis, and 3 (4.5%) had CADM. There were 8 patients with overlap syndromes. Dyspnoea and a dry cough were the most common presenting symptoms, in 52 (78.8%) and 36 (54.5%) patients, respectively. Bibasal crackles were noted in 38 patients (57.6%). Interstitial lung disease (ILD), followed by infection and pulmonary hypertension (PH), were documented in 46 (69.7%), 16 (24.2%) and 9 (13.6%) patients, respectively. Nine patients had microbiologically confirmed pulmonary tuberculosis. Patients who were anti-Jo1 antibody positive (n=16) had higher levels of acute inflammatory markers and muscle enzymes compared with the rest of the patients (p<0.0001). Dyspnoea and bibasal crackles were associated with significantly lower baseline and 12-month lung function parameters. Nonspecific interstitial pneumonia was the most common radiological pattern of ILD, present in 25 (62.5%) of the patients with ILD.
Conclusion. ILD was the most prevalent complication in this study of SA patients with IIMs. Pulmonary infections and PH were also significant contributors to morbidity. The presence of dyspnoea and crackles was predictive of lower baseline PFTs in this population.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under Attribution-Non Commercial International Creative Commons Attribution (CC-BY-NC 4.0) License. Under this license, authors agree to make articles available to users, without permission or fees, for any lawful, non-commercial purpose. Users may read, copy, or re-use published content as long as the author and original place of publication are properly cited.
Exceptions to this license model is allowed for UKRI and research funded by organisations requiring that research be published open-access without embargo, under a CC-BY licence. As per the journals archiving policy, authors are permitted to self-archive the author-accepted manuscript (AAM) in a repository.
How to Cite
References
1. Bohan A, Peter JB. Polymyositis and dermatomyositis. N Engl J Med 1975;292(7):344- 347. https://doi.org/10.1056/NEJM197502132920706
2. Hallowell RW, Ascherman DP, Danoff SK. Pulmonary manifestations of polymyositis/ dermatomyositis. Semin Respir Crit Care Med 2014;35(2):239-248. https://doi. org/10.1055/s-0034-1371528
3. Marie I, Hachulla E, Chérin P, et al. Interstitial lung disease in polymyositis and dermatomyositis. Arthritis Rheum 2002;47(6):614-622. https://doi.org/10.1002/ art.10794
4. Fathi M, Lundberg IE, Tornling G. Pulmonary complications of polymyositis and dermatomyositis. Semin Respir Crit Care Med 2007;28(4):451-458. https://doi. org/10.1055/s-2007-985666
5. Chinniah KJ, Mody GM. The spectrum of idiopathic inflammatory myopathies in South Africa. Clin Rheumatol 2021;40(4):1437-1446. https://doi.org/10.1007/s10067- 020-05048-w
6. Cobo-Ibáñez T, López-Longo F-J, Joven B, et al. Long-term pulmonary outcomes and mortality in idiopathic inflammatory myopathies associated with interstitial lung disease. Clin Rheumatol 2019;38(3):803-815. https://doi.org/10.1007/s10067- 018-4353-2
7. Marie I, Hatron PY, Dominique S, Cherin P, Mouthon L, Menard JF. Short-term and long-term outcomes of interstitial lung disease in polymyositis and dermatomyositis: A series of 107 patients. Arthritis Rheum 2011;63(11):3439-3447. https://doi. org/10.1002/art.30513
8. Chen F, Li S, Wang T, Shi J, Wang G. Clinical heterogeneity of interstitial lung disease in polymyositis and dermatomyositis patients with or without specific autoantibodies. Am J Med Sci 2018;355(1):48-53. https://doi.org/10.1016/j.amjms.2017.07.013
9. Lega JC, Fabien N, Reynaud Q, et al. The clinical phenotype associated with myositis-specific and associated autoantibodies: A meta-analysis revisiting the so-called antisynthetase syndrome. Autoimmun Rev 2014;13(9):883-891. https://doi. org/10.1016/j.autrev.2014.03.004
10. Mimori T, Imura Y, Nakashima R, Yoshifuji H. Autoantibodies in idiopathic inflammatory myopathy: An update on clinical and pathophysiological significance. Curr Opin Rheumatol 2007;19(6):523-529. https://doi.org/10.1097/BOR.0b013e3282f01a8c
11. Euwer RL, Sontheimer RD. Amyopathic dermatomyositis (dermatomyositis siné myositis): Presentation of six new cases and review of the literature. J Am Acad Dermatol 1991;24(6 Pt 1):959-966.
12. Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general US population. Am J Respir Crit Care Med 1999;159(1):179-187. https://doi.org/10.1164/ajrccm.159.1.9712108
13. Barst RJ, McGoon M, Torbicki A, et al. Diagnosis and differential assessment of pulmonary arterial hypertension. J Am Coll Cardiol 2004;43(12 Suppl S):40S-47S. https://doi.org/10.1016/j.jacc.2004.02.032
14. Gotway MB, Freemer MM, King TE Jr. Challenges in pulmonary fibrosis. 1: Use of high-resolution CT scanning of the lung for the evaluation of patients with idiopathic interstitial pneumonias. Thorax 2007;62(6):546. https://doi.org/10.1136/ thx.2004.040022
15. Cottin V, Thivolet-Béjui F, Reynaud-Gaubert M, et al. Interstitial lung disease in amyopathic dermatomyositis, dermatomyositis and polymyositis. Eur Respir J 2003;22(2):245-250. https://doi.org/10.1183/09031936.03.00026703
16. Douglas WW, Tazelaar HD, Hartman TE, et al. Polymyositis-dermatomyositis- associated interstitial lung disease. Am J Respir Crit Care Med 2001;164(7):1182-1185. https://doi.org/10.1164/ajrccm.164.7.2103110
17. Fathi M, Dastmalchi M, Rasmussen E, Lundberg IE, Tornling G. Interstitial lung disease, a common manifestation of newly diagnosed polymyositis and dermatomyositis. Ann Rheum Dis 2004;63(3):297-301. https://doi.org/10.1136/ ard.2003.006122
18. LongK,DanoffSK.Interstitiallungdiseaseinpolymyositisanddermatomyositis.Clin Chest Med 2019;40(3):561-572. https://doi.org/10.1016/j.ccm.2019.05.004
19. Debray MP, Borie R, Revel MP, et al. Interstitial lung disease in anti-synthetase syndrome: Initial and follow-up CT findings. Eur J Radiol 2015;84(3):516-523. https:// doi.org/10.1016/j.ejrad.2014.11.026
20. Ebner L, Christodoulidis S, Stathopoulou T, et al. Meta-analysis of the radiological and clinical features of usual interstitial pneumonia (UIP) and nonspecific interstitial pneumonia (NSIP). PLoS ONE 2020;15(1):e0226084. https://doi.org/10.1371/journal. pone.0226084
21. BourosD,WellsAU,NicholsonAG,etal.Histopathologicsubsetsoffibrosingalveolitis in patients with systemic sclerosis and their relationship to outcome. Am J Respir Crit Care Med 2002;165(12):1581-1586. https://doi:.org/10.1164/rccm.2106012
22. Castelino FV, Varga J. Interstitial lung disease in connective tissue diseases: Evolving concepts of pathogenesis and management. Arthritis Res Ther 2010;12(4):213. https:// doi.org/10.1186/ar3097
23. CottinV,CordierJF.Velcrocrackles:Thekeyforearlydiagnosisofidiopathicpulmonary fibrosis? Eur Respir J 2012;40(3):519-521. https://doi.org/10.1183/09031936.00001612 24. Cruellas MG, Viana Vdos S, Levy-Neto M, Souza FH, Shinjo SK. Myositis-specific and myositis-associated autoantibody profiles and their clinical associations in a large series of patients with polymyositis and dermatomyositis. Clinics (Sao Paulo)
2013;68(7):909-914. https://doi.org/10.6061/clinics/2013(07)04
25. Gupta L, Aggarwal R, Naveen R, et al. High prevalence of active tuberculosis in adults and children with idiopathic inflammatory myositis as compared with systemic lupus erythematosus in a tuberculosis endemic country: Retrospective data review from a tertiary care centre in India. Mediterr J Rheumatol 2021;32(2):134-142. https://doi.
org/10.31138/mjr.32.2.134
26. 2Yang Z, Lin F, Qin B, Liang Y, Zhong R. Polymyositis/dermatomyositis and malignancy risk: A metaanalysis study. J Rheumatol 2015;42(2):282-291. https://doi. org/10.3899/jrheum.140566